Foresite Capital Opportunity Management V, LLC Theseus Pharmaceuticals, Inc. Transaction History
Foresite Capital Opportunity Management V, LLC
- $33.3 Million
- Q3 2022
A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Theseus Pharmaceuticals, Inc. stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 959,275 shares of THRX stock, worth $0. This represents 16.71% of its overall portfolio holdings.
Number of Shares
959,275
Previous 959,275
-0.0%
Holding current value
$0
Previous $5.31 Million
4.88%
% of portfolio
16.71%
Previous 13.37%
Shares
2 transactions
Others Institutions Holding THRX
# of Institutions
2Shares Held
1.03MCall Options Held
0Put Options Held
0About Theseus Pharmaceuticals, Inc.
- Ticker THRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,713,400
- Description
- Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...